A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer
Clinical trial NCT02735980 · COMPLETED
Trial details
- NCT number
- NCT02735980
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-11
- Primary completion
- 2017-07-31
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.